Does TENOFOVIR DISOPROXIL Cause Hepatic failure? 129 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Hepatic failure have been filed in association with TENOFOVIR DISOPROXIL (Tenofovir Disoproxil Fumarate). This represents 0.5% of all adverse event reports for TENOFOVIR DISOPROXIL.
129
Reports of Hepatic failure with TENOFOVIR DISOPROXIL
0.5%
of all TENOFOVIR DISOPROXIL reports
83
Deaths
30
Hospitalizations
How Dangerous Is Hepatic failure From TENOFOVIR DISOPROXIL?
Of the 129 reports, 83 (64.3%) resulted in death, 30 (23.3%) required hospitalization, and 5 (3.9%) were considered life-threatening.
Is Hepatic failure Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENOFOVIR DISOPROXIL. However, 129 reports have been filed with the FAERS database.
What Other Side Effects Does TENOFOVIR DISOPROXIL Cause?
Bone density decreased (10,586)
Renal injury (9,255)
Skeletal injury (8,320)
Chronic kidney disease (7,230)
Osteonecrosis (7,182)
Bone loss (7,040)
Multiple fractures (6,793)
Renal failure (6,388)
Osteoporosis (5,302)
Tooth loss (4,483)
What Other Drugs Cause Hepatic failure?
ACETAMINOPHEN (1,392)
RIBAVIRIN (888)
CYCLOPHOSPHAMIDE (629)
METHOTREXATE (598)
BEVACIZUMAB (558)
SOFOSBUVIR (525)
RITUXIMAB (513)
VINCRISTINE (468)
DOXORUBICIN (462)
PREDNISOLONE (425)
Which TENOFOVIR DISOPROXIL Alternatives Have Lower Hepatic failure Risk?
TENOFOVIR DISOPROXIL vs TEPLIZUMAB-MZWV
TENOFOVIR DISOPROXIL vs TEPOTINIB
TENOFOVIR DISOPROXIL vs TEPROTUMUMAB
TENOFOVIR DISOPROXIL vs TEPROTUMUMAB-TRBW
TENOFOVIR DISOPROXIL vs TERAZOSIN